Haematological and biochemical ef ects of sulphad midine were studied in Nigerian mongrel dogs. Five Nigerian mongrel dogs of either sex weighing between 7 and 12 kg were used for the study. The pretreatment blood and serum samples were collected and the weight of animals taken before the administrat on of 100 mg/kg body weight for a period of 7 days. The animals were weighed daily. The results showed that there was no significant difference between preadministrat on and post administration weights ( 
INTRODUCTION
The systemic availability of a drug is the amount of administered drug which reaches the systemic circulation intact (Graham-Smith and Aronson, 1992) . Measurement of drug concentration in the blood and urine are performed to determine the need for adjustment of the dosage or of the schedule of administration (Saganuwan et al., 2003) . Sulphadimidine, a systemic sulphonamide, has maintained an active place in the armamentary of antimicrobial drugs used in veterinary medicine (Saganuwan et al., 2003) . It has been proven clinically to be useful for wide range of microbial diseases caused by gram negative and positive bacteria, Nocardia, Actinomyces, Chlamydia, Toxoplasma and Coccidia (Bevil, 1982) . Sulphadimidine is 79 % plasma protein bound with half-life of 3.88 to 15.4 hours and has particularly large percentage (60 -90 %) excreted as acetylated derivatives (Saganuwan et al., 2003) . The estimation of bioavailability of sulphadimidine is usually based on the cumulative urinary excretion of the drug (Baggot, 2001) .
The protein fractions in the blood are commonly estimated in the serum and do not include fibrinogen that will be precipitated when the blood clots. The main serum proteins are albumin and globulin (Kombo-Owiye and Reid, 1991) . The extent of drug binding to plasma proteins varies with the concentrations of drug and plasma protein, the affinity being between drug-binding protein and drug and the number of binding sites per molecule. Within the range of therapeutic concentrations, the extent of drug binding in healthy animals is concentration dependent for some drugs and animal models (Baggot, 2001) .
Albumin largely accounts for the binding of acidic drugs such as sulphonamides in plasma. The range of total plasma/serum protein concentration (6.0 -8.5 g/dl) is similar in domestic animals and humans (Baggot, 2001) . Species variation in the binding of acidic drugs may be attributed to differences in the configuration of the plasma albumin that would affect the binding capacity of protein (Baggot, 2001) . The aim of the present study was not to establish only normal haematological and biochemical parameters in the healthy dogs but also, to investigate the effects of sulphadimidine on these parameters. The study may serve as a guide to avoiding adverse effects that may be caused by sulphadimidine in Nigerian mongrel dogs as species variation, sex, age, disease condition, environment and nutritional factors sometimes play great role in disposition kinetics of a particular drug.
MATERIAL AND METHODS
Experimental Animals: Five Nigerian mongrel dogs of either sex weighing between 7 and 12 kg were used for this study. The dogs were purchased in Makurdi, Benue State, Nigeria from a dog owner. The dogs were borne the same day and from the same mother. But they were 6 -7 months old and fed daily with boiled rice, beans and meat, water was provided adlibitum.
Drug Administrations and Sample Collection:
Sulphadimidine was intramuscularly administered at the dose rate of 100 mg/kg body weight into thigh muscles of the 5 dogs daily for a period of 7 days. Prior to administration of sulphadimidine, control blood samples were collected from the dogs: 2 mls of blood was collected from the cephalic vein of each dog into test tubes containing ethylenediamminetetraacetate (EDTA) as anticoagulant for haematological parameters. Another 4 -5 mls of whole blood was collected from each dog but allowed to coagulate and serum collected for quantitative in vitro determination of biochemical parameters: liver function test and electrolytes determination.
After that, the animals were weighed before sulphadimidine administration and after sulphadimidine administration for 7 days. At the end of 7 days trial, another 1 -2 mls of blood sample was collected from the cephalic vein of each dog into EDTA bottle and 4 -5 mls of whole blood was collected from each dog and allowed to coagulate in order to obtain serum for determination of haematological and biochemical parameters respectively. All dogs were weighed.
Determination
of Haematological and Biochemical Parameters: Total blood cells count was done using the method of Baker (1985) . Total protein was determined using biuret method (Tietz, 1995) . Albumin was determined using bromocresol green method (Doumas, 1971) . But conjugated bilirubin and total bilirubin were determined using the method of Jendrassik and Grof (1938) whereas Serum Glutamic Oxaloacetic Transaminase (SGOT) and Serum Glutamic Pyruric Transaminase (SGPT) were determined using the method of Reitman and Frankel (1957) . Sodium ion (Na + ) and potassium ion (K + ) were determined using flame photometric method (Fawcett and Scott, 1960) . Both bicarbonate (HCO -3 ) and chloride (CL -) ions were determined using titration method (Chaney and Marbach, 1962) .
Statistical Analysis -The data on weight gain or loss, haematological and biochemical parameters were expressed as mean ± S.D. Tests for significance between mean parameters in respect of preadministration and post administration values were performed using student 't' test (Petrie and Watson, 2002) .
RESULTS
The mean weight of the animals before administration of sulphadimidine was 8.8 ±2.04 kg a whereas the mean weight of the animals post administration of sulphadimidine was 8.77 ± 0.89 kg b (P > 0.05) i.e. there was no significant difference between the weight of the animals before and after the treatment with sulphadimidine (Table 1) . Liver function test revealed the increase level of total bilirubin and alkaline phosphatase (P<0.05). However, total protein, albumin, conjugated bilirubin, serum glutamic oxaloacetic transaminase (SGOT) and serum glutamic pyruvic transaminase (SGPT) did not increase significantly P>0.05) ( Table 3) . Electrolytes titration has shown that sodium ion (Na + ) potassium ion (K + ), chloride ion (Cl -) and bicarbonate ion (HC0 -3 ) did not increase significantly (P>0.05) ( Table 4) .
DISCUSSION
The mean weight gain (8.8 ± 2.04 kg a ) of the animals before sulphadimidine administration is comparable with the weight gain (8.77 ± 0.89 kg b ) of animals after the sulphadimidine treatment. This shows that sulphadimidine has no effect on weight gain or loss. But the decrease in packed cell volume (P > 0.05) is a clear demonstration of report of Willard et al (1989) that in the dog, the severity of the anaemia is arbitrarily indicated by PCV range and that PCV value of 20 -29 % was moderate. Hence sulphadimidine cause anaemia of moderate value (26.4 ± 3.36 % a ) in dogs. Although anaemia is the most common erythrocyte disorder that can cause a variety of clinical signs (e.g. weakness, lethargy, heart murmur, pica) or may be sub-clinical and detected only as part of a diagnostic work up (Willard et al., 1988) , the above mentioned signs of anaemia were not noticed before the experiment. The results of liver function test have shown total protein value of 68.32 ± 1.69g/l a in Nigerian mongrel dogs. This agrees with the report of Baggot (2001) that the range (60-86 g/l) of total plasma/serum protein concentration is similar in domestic animals and human, but this range was not affected by sulphadimidine administration (P>0.05). However, the total bilirubin decrease (P<0.05) is a clear demonstration of report of Willard et al (1989) that decreased bilirubin (12.32 ±1.41 µmol/l a ) in comparison with (18.5 ±2.01 µmol/l b ) may be due to drugs that displace bilirubin from albumin. This is further confirmed by Prescott et al (2000) that sulphonamides are bound to plasma proteins to an extent varying from 15% to 90%. But there is variation among species in binding of individual sulphonamides.
Moreso, significant difference between preadministration value (130 ± 9.61 µg/l a ) and post administration value (114.2 ±5.72 µg/l b ) of alkaline phosphatase may be associated with the injected sulphadimidine which might have inhibited hepatic enzyme. This is supported by Willard et al (1979) that bone-origin of serum alkaline phosphatase is commonly increased in animals less than 6 to 8 months old. But in this study sulphadimidine has decreased alkaline phosphatase (P < 0.05).
The decreased level of alkaline phosphatase may affect bone mineralization during bone formation. This is supported by Murray et al (2000) that alkaline phosphatase contributes to mineralization but in itself is not sufficient.
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